Evidence map›Paper›PMID 27057274›Full record

ArticleOxidative medicine and cellular longevity2016

Neuregulin 1 Promotes Glutathione-Dependent Neuronal Cobalamin Metabolism by Stimulating Cysteine Uptake.

Yiting Zhang, Nathaniel Hodgson, Malav Trivedi, Richard Deth

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Neuregulin1 Attenuates HNeurotoxicity research · 2019
    Article
  7. Brain iron loading impairs DNA methylation and alters GABAergic function in mice.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Yiting ZhangDepartment of Pharmaceutical Sciences, Northeastern University, Boston, MA 02115, USA.
Nathaniel HodgsonDepartment of Neurology, F.M. Kirby Neurobiology Center, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA.ORCID 0000-0001-8299-3963
Malav TrivediDepartment of Pharmaceutical Sciences, Nova Southeastern University, Fort Lauderdale, FL 33328, USA.
Richard DethDepartment of Pharmaceutical Sciences, Northeastern University, Boston, MA 02115, USA; Department of Pharmaceutical Sciences, Nova Southeastern University, Fort Lauderdale, FL 33328, USA.
Northeastern University · USBoston Children's Hospital · USNova Southeastern University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neuregulin 1 (NRG-1) is a key neurotrophic factor involved in energy homeostasis and CNS development, and impaired NRG-1 signaling is associated with neurological disorders. Cobalamin (Cbl), also known as vitamin B12, is an essential micronutrient which mammals must acquire through diet, and neurologic dysfunction is a primary clinical manifestation of Cbl deficiency. Here we show that NRG-1 stimulates synthesis of the two bioactive Cbl species adenosylcobalamin (AdoCbl) and methylcobalamin (MeCbl) in human neuroblastoma cells by both promoting conversion of inactive to active Cbl species and increasing neuronal Cbl uptake. Formation of active Cbls is glutathione- (GSH-) dependent and the NRG-1-initiated increase is dependent upon its stimulation of cysteine uptake by excitatory amino acid transporter 3 (EAAT3), leading to increased GSH. The stimulatory effect of NRG-1 on cellular Cbl uptake is associated with increased expression of megalin, which is known to facilitate Cbl transport in ileum and kidney. MeCbl is a required cofactor for methionine synthase (MS) and we demonstrate the ability of NRG-1 to increase MS activity, and affect levels of methionine methylation cycle metabolites. Our results identify novel neuroprotective roles of NRG-1 including stimulating antioxidant synthesis and promoting active Cbl formation.

Indexed as

5-Methyltetrahydrofolate-Homocysteine S-MethyltransferaseAndrostadienesCell Line, TumorCysteineExcitatory Amino Acid Transporter 3GlutathioneHumansLow Density Lipoprotein Receptor-Related Protein-2MethylationNeuregulin-1NeuronsReal-Time Polymerase Chain ReactionRNA, MessengerS-AdenosylmethionineSignal TransductionVitamin B 125-Methyltetrahydrofolate-Homocysteine S-MethyltransferaseAndrostadienesCysteineExcitatory Amino Acid Transporter 3GlutathioneLow Density Lipoprotein Receptor-Related Protein-2Neuregulin-1RNA, MessengerS-AdenosylmethionineSLC1A1 protein, humanVitamin B 12Wortmannin

Identifiers

PMID27057274
PMCPMC4709767
OpenAlexW2208844090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.